(Q44557351)

English

Successful clearance of hepatitis B virus after allogeneic stem cell transplantation: beneficial combination of adoptive immunity transfer and lamivudine

scientific article published in September 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Successful clearance of hepatitis B virus after allogeneic stem cell transplantation: beneficial combination of adoptive immunity transfer and lamivudine (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Tetsuhiro Chiba

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Osamu Yokosuka

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Shigemasa Goto

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Kenichi Fukai

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Fumio Imazeki

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hideki Shishido

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Mitsuro Narita

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hiromitsu Saisho

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

European Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

220-223

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Reactivated fulminant hepatitis B virus replication after bone marrow transplantation: clinical course and possible treatment with ganciclovir

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Long-term therapy of chronic hepatitis B with lamivudine.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Hepatitis B associated liver failure following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Lamivudine is safe and effective in fulminant hepatitis B

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Prevention of hepatitis development by interferon-alpha in HBV carriers treated with intensive chemotherapy: a pilot study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

21 January 2018

Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00114.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1600-0609.2003.00114.X

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

release_ldwsvrv3qncetk6wdjvirf2zfe

1 reference

https://api.fatcat.wiki/v0/release/ldwsvrv3qncetk6wdjvirf2zfe

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44557351&oldid=2095035541"